Back to Search
CHRISTOPHER AZZOLI, MD
MD
Medical Oncology Physician
NPI: 1861463895IndividualAccepts Medicare
Specialties, Licenses & Credentials
Medical Oncology PhysicianPrimary
Internal Medicine — Medical Oncology
Code: 207RX0202X
214873(NY)
CMS Specialties
PrimaryHEMATOLOGY/ONCOLOGY
Education
JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE
Class of 1996
Research & Publications (20)
Molecularly tailored adjuvant chemotherapy for resected non-small cell lung cancer: a time for excitement and equipoise.
PMID 18166846·J Thorac Oncol·2008
6-review
A phase II tolerability study of cisplatin plus docetaxel as adjuvant chemotherapy for resected non-small cell lung cancer.
PMID 17607120·J Thorac Oncol·2007
3-trial
A phase 1 study of pralatrexate in combination with paclitaxel or docetaxel in patients with advanced solid tumors.
PMID 17473201·Clin Cancer Res·2007
3-trial
Can adjuvant chemotherapy improve survival in patients with early-stage, resected non-small-cell lung cancer?
PMID 16270095·Nat Clin Pract Oncol·2005
3-trial
Gemcitabine-induced peripheral edema: report on 15 cases and review of the literature.
PMID 12796593·Am J Clin Oncol·2003
5-case
A phase I trial of perillyl alcohol in patients with advanced solid tumors.
PMID 12695855·Cancer Chemother Pharmacol·2003
3-trial
A phase I trial of SJG-136 (NSC#694501) in advanced solid tumors.
PMID 19672598·Cancer Chemother Pharmacol·2010
3-trial
Use of epidermal growth factor receptor/Kirsten rat sarcoma 2 viral oncogene homolog mutation testing to define clonal relationships among multiple lung adenocarcinomas: comparison with clinical guidelines.
PMID 19376842·Chest·2010
4-observational
Randomized phase II study of pulse erlotinib before or after carboplatin and paclitaxel in current or former smokers with advanced non-small-cell lung cancer.
PMID 19047285·J Clin Oncol·2009
3-trial
Chemoradiation for unresectable stage III non-small cell lung cancer.
PMID 19038729·Semin Thorac Cardiovasc Surg·2008
6-review
Therapeutic options for the treatment of advanced lung cancer: introduction.
PMID 19038725·Semin Thorac Cardiovasc Surg·2008
8-other
Prognostic and therapeutic implications of EGFR and KRAS mutations in resected lung adenocarcinoma.
PMID 18303429·J Thorac Oncol·2008
8-other
Phase I/II trial of weekly intravenous 130-nm albumin-bound paclitaxel as initial chemotherapy in patients with stage IV non-small-cell lung cancer.
PMID 18235124·J Clin Oncol·2008
3-trial
Cancer Care Ontario and American Society of Clinical Oncology adjuvant chemotherapy and adjuvant radiation therapy for stages I-IIIA resectable non small-cell lung cancer guideline.
PMID 17954710·J Clin Oncol·2007
6-review
Phase 1 trial of everolimus and gefitinib in patients with advanced nonsmall-cell lung cancer.
PMID 17577220·Cancer·2007
3-trial
Cisplatin versus carboplatin for patients with metastatic non-small-cell lung cancer--an old rivalry renewed.
PMID 17551137·J Natl Cancer Inst·2007
4-observational
A phase I trial of intermittent high-dose gefitinib and fixed-dose docetaxel in patients with advanced solid tumors.
PMID 16896930·Cancer Chemother Pharmacol·2007
3-trial
Adjuvant chemotherapy for resected non-small-cell lung cancer--ANITA takes the stage.
PMID 16945762·Lancet Oncol·2006
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1275 YORK AVE
NEW YORK, NY 10021 - Phone
- (646) 227-3813
Quick Facts
- NPI
- 1861463895
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 30
- Publications
- 20
Are you this provider?
Claim Your Profile